Admission to the THSTI-JNU PhD Program for the Academic Year 2018-2019-Winter Session 2018
No. of Seats : A total of up to 15 candidates may be selected this year, if found suitable. The number of selected candidates may be less if sufficient candidates do not secure the minimum credentials required for admission.
Eligibility: The candidate must fulfill one of the following criteria:
Group A: must have qualified in the junior research fellowship examination of CSIR, UGC, ICMR, DBT (category I only),BINC (for bioinformatics & computer science) or NBHM which provides fellowship for the entire duration (5 years) of their PhD program. Should have a Master’s degree in any branch of biomedical/life sciences (including veterinary science, public health),bioinformatics, computer science or Mathematics from a recognized university with at least 55% marks or its equivalent (e.g.: grade B in the UGC 7-point scale) or a B Tech in Biotechnology.
Group B: MBBS. BE/B Tech (Computer Science) with a valid GATE qualifying score. MSc - Mathematics
Candidates appearing in the final qualifying examination may also apply. However, they will be required to fulfill the above academic/ fellowship requirements at the time of joining the PHD program.
A relaxation in marks/grade during Master’s Degree for those belonging to SC/ST/OBC (non-creamy layer)/differently-abled and any other categories will be applicable as per the UGC notification, 5th May 2016 or subsequent notification in effect of at the time of interview.
Fellowship : Students from group A recommended for admission to the PhD program and holding fellowship from any of the above agencies will be required to utilize their own fellowship. Candidates with professional degrees (Group B) selected through the admission process will be awarded THSTI fellowships equivalent to the CSIR-UGC Fellowship amount.
Application Fee : Non-refundable application fee of Rs. 500 for General and OBC candidates, and Rs. 250 for SC/ST/differently-abled candidates should be paid by bank draft in favor of Translational Health Science and Technology Institute payable at Faridabad. You may also deposit the fees by bank transfer as per the payee account details given below and may submit the proof of remittance.
Payee name: Translational Health Science and Technology Institute
Payee bank: State Bank of India, Faridabad Main Branch, Neelam Chowk NIT, Faridabad-121001
Account no.: 32497747957
IFSC Code: SBIN0000734
Selection Procedure : Names of shortlisted candidates will be announced on our website by 17th November. Shortlisted candidates will have to appear for an admission test at THSTI on the 3 rd of December at 9:30 am. Applicants who clear the admission test will be interviewed on 3 rd and 4 th December 2018. Final selection will be made based on the applicant’s performance in the interview and the list of selected candidates will be published on the THSTI website within one working week of the interview. Selected candidates should interact with potential PhD supervisors and provide their choice of supervisors for lab rotations by 4 PM on 24th December 2018.
How To Apply For Admission to the THSTI-JNU PhD Program for the Academic Year 2018-2019-Winter Session 2018
Candidates fulfilling the above requirements must Apply Online. Please take a print out of the application, sign and send it to the Officer (Academics) of the institute at the above address along with the application fee and self-attested copies of documents in support of eligibility so as to reach by 10th November 2018.
About Translational Health Science and Technology Institute THSTI
The Translational Health Science and Technology Institute (THSTI), part of an emerging health biotech science cluster, is an ambitious initiative which creates the unique institutional environment for the conduct of truly multidisciplinary research that translates scientific and technological advancements into medical innovations that will improve public health. It also seeks to establish collaborations with research institutions and hospitals around India, making this a national undertaking. The goal: affordable technologies and solutions that address global healthcare.